fortis-logo

From Bench to Production: Streamlining Lyophilized Reagent Manufacturing

Close-up of a gloved hand holding lyophilized beads with tweezers, with more beads scattered on a dark surface in the background

How to scale a lyophilization project into manufacturing

Scaling a lyophilization project from R&D to Manufacturing

Transitioning a lyophilized (freeze-dried) reagent from research to manufacturing can be challenging, even for experienced teams. The process involves balancing formulation science, engineering controls, documentation, and scale-up logistics while simultaneously keeping timelines realistic, costs under control and product stability uncompromised. An experienced contract manufacturer like International Point of Care (IPOC, a wholly owned subsidiary of Fortis) can simplify these challenges using rapid, structured, and low-risk processes. IPOC’s unique workflow allows delivery of a ready-to-use lyophilized product in as little as 10 working days, helping R&D teams quickly validate performance and accelerate commercialization. Below are the essential stages of a successful lyophilization transfer and how IPOC can help scale your project.

Steps to a Successful Lyophilization Transfer

Common Pitfalls in R&D-to-Manufacturing Transfer

One of the most common problems is underestimating the complexity of moving a liquid formulation from the benchtop to production scale in a lyophilized format. It is a mistake to think a working liquid assay will easily transfer to a lyophilized product and there are several issues that can derail the progress. Freeze-drying, also known as lyophilization, is a multi-step process (formulation, freezing, primary and secondary drying, moisture protective packaging) in which water in the form of ice under low pressure is removed from a material by a process called sublimation. This process has found many applications to produce high quality food, pharmaceuticals and diagnostic products. It can simplify product design, increase product shelf-life, and reduce shipping costs by eliminating cold chain requirements.

However, lyophilization is not simply “freezing and drying” and requires both process expertise and equipment. Without experienced operators, it’s easy to damage biological activity through suboptimal freezing rates, poor choice of excipient, mistaken primary drying temperatures, or improper vacuum control.

There might also be equipment limitations since laboratory freeze-dryers often lack the temperature uniformity, shelf control, or vacuum precision required for reproducible manufacturing cycles. Scaling from a 2-mL vial to a 96-well format or other lyophilized bead format requires careful thermal modeling and load validation. Manufacturing lyophilized reagents require may infrastructure with a suitable environments such as cleanroom conditions, controlled humidity, nitrogen handling, and validated packaging system. Regulatory expectations for process reproducibility, traceability, and lot release often exceed what an R&D environment can support. The results are inconsistencies in the research/scale phase being transferred into full manufacturing.

When R&D teams attempt to build these capabilities internally, they often discover the bottleneck isn’t science, but rather infrastructure, training, and compliance. IPOC’s core focus is to remove those barriers. Instead of your team building a freeze-drying facility, IPOC provides an immediate, turnkey path to a market-ready lyophilized product, allowing your research team to stay focused on assay innovation while IPOC handles the manufacturing science.

Define the Product Requirements

First, begin with your developmental liquid assay type (PCR, ELISA, enzymatic, immunochromatographic, etc.). The only component that should be remaining is the choice of excipient/stabilizer that will be used. The development team should already have determined assay/design format (tube, cartridge, or plate), intended shelf life, and storage conditions. Providing formulation details such as buffer composition, enzyme source, and stabilizers already tested in development phase, will help the transition. Information about the final lyophilized manufacturing process is also important to know: will the lyophilized product be made continuously, in batches, or on-demand? How will the manufacturing team handle the final lyophilized product? Does the team have the right lyophilization instrumentation and QC instrumentation?

IPOC’s technical team begins with the product requirements and translates these details into manufacturable parameters. They assess reagent compatibility with lyophilization (salt balance, anti-freeze agents, surfactants), packaging constraints, and moisture sensitivity. This early collaboration avoids reformulation surprises later and ensures that your prototype will behave identically once lyophilized.

Choose a Lyophilization Format

For diagnostic and molecular applications, selecting the right format – lyophilized beads, cakes, or powders, can determine performance consistency and workflow integration. Lyo-bead (beads can be scaled in size range 1.5mm-5.0mm diameter and can contain 3-75 μL reagent) provide fast reconstitution and precise dosing for PCR microplates or cartridges and can also be used for lateral flow or tube-based applications.

IPOC offers pre-validated procedures with fill volumes, and cycle templates for each format, ensuring optimal drying efficiency with minimal loss of biological activity. This means your reagents can move rapidly from liquid prototype to lyophilized pilot production without designing hardware or programming freeze-drying cycles from scratch.

Formulation Optimization and Stability Screening

The right combination of cryoprotectants and lyoprotectants, influences the success of lyophilization. Excipients such as sugars (trehalose, sucrose), amino acids, and polymers prevent protein denaturation and maintain structural integrity of lyophilized products. In a conventional R&D-to-manufacturing handoff, this phase can take weeks and is often highly re-iterative. That’s because it requires multiple rounds of experimental iteration, equipment scheduling, and sequential testing. Each potential formulation must be frozen, lyophilized, rehydrated, and functionally tested for performance. Each freeze-drying run can take 24–48 hours, with additional time needed for moisture analysis, visual inspection, and stability testing at different temperatures all part of the process.

Our experience drove us to develop a new approach where we can compress this process from months into days by applying a “library” of pre-validated excipient systems tailored for enzymes, nucleotides, antibodies, or whole reaction mixes. IPOC's in-house formulation specialists adjust concentration ratios to meet the required reconstitution time, residual moisture target, and storage stability profile. The result: you move from formulation to manufacturable pilot material in days, not weeks.

Pilot Lyophilization and Process Qualification

Before any full-scale manufacturing can begin, a pilot lyophilization run or prototype batch is essential to verify how the formulation behaves under authentic manufacturing conditions. These small-scale production runs bridge the gap between benchtop development and commercial readiness. IPOC performs pilot lyophilization runs to verify cycle performance, monitoring shelf temperature, chamber pressure, and endpoint moisture. The output is a batch of production-equivalent material that allows your team to immediately test assay functionality and yield.

As IPOC maintains a fully qualified lyophilization suite with controlled humidity, vacuum systems, and flexible packaging, configurations your product’s pilot run already aligns with manufacturing-grade standards. This dramatically shortens the eventual scale-up time and provides a direct path to design-transfer documentation required for full scale manufacturing.

Fill-Finish and Packaging for Lyophilized Products

Once reagents are dried, the lyophilized powders and beads are highly sensitive to moisture, static charge, and mechanical stress. Even minor exposure to humidity during filling or packaging can impact residual moisture levels, reduce shelf life, or cause inconsistent rehydration. Handling these materials requires trained operators, humidity-controlled environments, and validated dispensing systems.

IPOC’s automated dispensing and packaging lines can fill custom microtubes, PCR plates, or aluminum pouches while using nitrogen flushing, ensuring low residual moisture and long shelf stability. Private-label packaging and lot-specific traceability are standard, enabling your team to receive a ready-to-ship lyophilized kit rather than loose vials of reagent. The benefit for many teams is immediate: there’s no need to source specialized equipment or manage GMP packaging protocols internally. IPOC’s experience with both small-scale pilot runs, and full production ensures consistent quality regardless of batch size.

Quality Control and Documentation

For teams new to lyophilization, scaling up from R&D batches to production volumes can expose hidden weaknesses in process control and documentation. Small variations in temperature gradients, vacuum hold times, or vial geometry can lead to inconsistent drying endpoints or collapsed cakes/beads. Manufacturing teams without prior lyophilization experience may also struggle with material flow, bead integrity, and line speed optimization.

Each product set is delivered with comprehensive QC data. Data about moisture content, visual inspection, and functional test results is included alongside batch records formatted for your quality management system (QMS). IPOC can also support accelerated and real-time stability studies to substantiate your shelf-life claims.

Validation and Next Steps

Validation is more than a formality. This is the bridge that connects manufacturing quality with assay performance. The results of functional assays, such as PCR efficiency, signal intensity, or rehydration time, can contribute to final adjustments of the lyophilization process. With IPOC’s process, validation data are rapidly cycled back to manufacturing, enabling immediate adjustments without restarting the entire development phase. This iterative, closed-loop approach allows lyophilized product sets to be refined and requalified within days, not weeks, ensuring that what’s tested in your lab mirrors what’s later produced on a larger scale.

With a 10-day turnaround, your team can receive lyophilized product samples for immediate functional validation. This may include running a PCR amplification or immunoassay to confirm equivalence to the liquid version. Any required adjustments can be quickly cycled back into a second iteration, supported by IPOC’s pre-qualified process templates.

Partnering for Success: Contract Lyophilization Services That Accelerate Scale-Up

How IPOC Makes It Easier

IPOC Factor that makes it easier for scaling-up The Fortis Edge
End-to-end expertise From formulation to kitting and packaging, all steps are performed in-house.
Pre-validated excipients With over 24 years’ experience, Fortis has the strongest pre-validated excipient portfolio.
Rapid prototyping 10-day delivery enables immediate functional testing.
Manufacturing-ready documentation cGMP and ISO 13485 quality system
Scalable production Seamless transition from pilot to thousands of kits.

Why Choose Fortis for Lyophilization Manufacturing

Bringing a lyophilized reagent from R&D to manufacturing can be a complex process requiring domain expertise and specialized infrastructure. The transfer phase is often iterative and can be long as different cryoprotectants and lyoprotectants are evaluated. Handling lyophilized product must be performed under specific environmental conditions. Without proper controls, manufactured lyophilized product may be susceptible to collapse or inconsistent performance.

With IPOC’s streamlined workflow, teams can compress timelines, reduce risk, and receive a production-grade, lyophilized format in just 10 working days—ready to test, validate, and scale.

Ready to Scale Your Lyophilization Process?

We have provided end-to-end contract lyophilization services for diagnostics, molecular biology, and reagent manufacturing for over two decades. From formulation optimization to kitting, our expert teams ensure quality and rapid turnaround.

Contact Us to discuss your project and accelerate your lyophilization path from research to manufacturing. Contact Us.

Lyophilization services

Contact us for more information: